2m 2m 2m 2m 2m 2m 2m
ATEA PHARMA (AVIR)
NASDAQ
$5.33+$0.02 (+0.28%)
Price as of Sep 11, 2026 6:44 PM EDT- $425.9MMarket Cap
- 69.11%1-Year Change
- BiotechnologyIndustry
ATEA PHARMA (AVIR)
$5.33+$0.02 (+0.28%)
Earnings Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 16.06% | ||
12-Month Momentum | 53.33% | ||
3-Month Risk Adjusted Momentum | 91.80% | ||
12-Month Risk Adjusted Momentum | 110.49% |
True Yield
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 3.07% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | AVIR | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -5 |